306-NSD2 targeting reverses plasticity in prostate cancer

The paper details research into the molecular mechanisms driving resistance to androgen receptor (AR) pathway inhibitors, such as enzalutamide, in advanced Castration-Resistant Prostate Cancer (CRPC). The study specifically addresses the lineage plasticity through which tumors can transdifferentiate into the highly resistant neuroendocrine subtype (CRPC-NE). Investigators identified that the epige...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动